期刊文献+

ERCC2/XPD基因缺失对苯并[a]芘所致DNA损伤修复的影响 被引量:3

Effect of deficient ERCC2/XPD gene on the repair of DNA damage induced by benzo[a]pyrene
下载PDF
导出
摘要 目的:探讨核苷酸切除修复交叉互补基因2(excision repair cross complementation group2/Xeroderma pigmentosum D,ERCC2/XPD)在苯并[a]芘所诱导的细胞DNA损伤与修复过程中的作用。方法:应用中国仓鼠卵巢细胞系CHO野生型AA8和ERCC2表达缺失型UV5作为细胞对照模型,MTT法比较两种细胞经苯并[a]芘处理后细胞抑制率的差别;彗星试验和Rad51免疫荧光试验检测不同浓度苯并[a]芘处理及修复24h后细胞DNA损伤修复的情况。结果:与野生型AA8细胞相比,UV5细胞对苯并[a]芘所致损伤更加敏感,细胞存活率降低(P<0.05)。彗星试验和Rad51免疫荧光试验结果显示,UV5细胞由于缺失ERCC2/XPD基因,修复苯并[a]芘所致DNA损伤能力降低(P<0.05)。结论:ERCC2/XPD蛋白在核苷酸切除修复中发挥解旋作用,对苯并[a]芘所致DNA损伤修复至关重要。 OBJECTIVE:To investigate ERCC2/XPD (excision repair cross complementation group 2/Xeroderma pigmentosum D) function in the repair of DNA damage induced by benzo[a]pyrene. METHODS:China hamster ovary (CHO) cell line including wild type AA8 and ERCC2/XPD defective mutant UV5,was set up as a cell contrast model. DNA damage levels at different time points after benzo[a]pyrene treatment were evaluated by MTT cell inhibition assay,modified comet assay and Rad51 immunofluorescence test. RESULTS:UV5 was more sensitive to benzo[a]pyrene when compared with AA8. The DNA damage caused by benzo[a]pyrene was repaired by AA8 but not by UV5. CONCLUSION:ERCC2/XPD,as an important helicase in nucleotide excision repair,could play a critical role in repairing DNA damage induced by benzo[a]pyrene.
出处 《癌变.畸变.突变》 CAS CSCD 2012年第6期405-409,共5页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 国家自然科学基金(30972506)
关键词 核苷酸切除修复交叉互补基因2 苯并[A]芘 核苷酸切除修复 AA8 UV5 ERCC2/XPD benzo[a]pyrene nucleotide excision repair AA8 UV5
  • 相关文献

参考文献13

  • 1Nesnow S, Tennant CH, Nelson GB, et al. Comparison of the genotoxic activities of the K-region dihydrodiol of benzo[a] pyrene with benzo[a]pyrenein mammalian ceils: morphological cell transformation; DNA damage; and stable covalent DNA adducts[J].MutatRes, 2002, 521 (1/2): 91-102.
  • 2Mensing T, Marczynski B, Engelhardt B, et al. DNA adduct formation of benzo[a]pyrene in white blood cells of workersexposed to polycyclic aromatic hydrocarbons[J]. Int J Hyg Environ Health, 2005, 208 (3): 173-178.
  • 3Gao D, Luo Y, Guevara D, et al. Benzo[a]pyrene and its metabolites combined with ultraviolet A synergistically induce 8-hydroxy-2'-deoxyguanosine via reactive oxygen species[J]. Free Radic Biol Med, 2005, 39 (9): 1177-1183.
  • 4Timothy PM, Jill OF, Justin PI, et al. ATP-stimulated, DNA-mediated redox signaling by XPD, a DNA repair and Transcription helicase[J]. J Am Chem Soc, 2011, 133 (41): 16378-16381.
  • 5Butkiewicz D, Rusin M, Enewold L, et al. Genetic polymorphisms in DNA repair genes and risk of lung cancer[J]. Carcinogenesis, 2001, 22(4): 593-597.
  • 6Tomescu D, Kavanagh G, Ha T, et al. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma[J]. Carcinogenesis, 2001, 22 (3): 403-408.
  • 7Sara B, Daniel RL. The role of p53 in DNA damage-mediated cytotoxicity overrides its ability to regulate nucleotide excision repair in human fibroblasts[J]. Mutagenesis, 2008, 23 (1): 43-50.
  • 8Tice RR, Agurell E, Anderson D. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing[J]. Environ MolMutagen, 2000, 35(3): 206-221.
  • 9Bermstein C, Bernstein H, Payne CM, et al. DNA repair/ proapoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis[J]. Mutr Res, 2002, 5(11): 145-178.
  • 10Vineis P, Manuguerra M, Kawoura FK, et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility[J]. J Natl Cancer Inst, 2009, 101 (1): 24-36.

二级参考文献6

  • 1Raymond E, Faivre S, Chaney S, et al. Cellular and molecular pharmacology of Oxaliplatin. Mol cancer Ther, 2002, 1: 227- 235.
  • 2Kim HM, Han SB, Kim MS, et al. Efficient fixation procedure of human leukemia cells in sulforhodamine B cytotoxicity assay. J Pharmacol Toxicol Methods, 1996,36: 163-169.
  • 3Almeida GM, Duarte TL, Steward WP, et al. Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay. Almeida GM, Duarte TL, Steward WP, Jones GD. DNA Repair. 2006,5:219-225.
  • 4Di Francesco AM, Ruggiero A, Riccardi R. Cellular and molecular aspects of drugs of the future: oxaliplatin. Cell Mol Life Scio 2002,59 : 1914-1927.
  • 5Reardon JT, Vaisman A, Chaney SG, et al. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and bisaceto ammine dichloro cyclohexylamine-platinum( Ⅳ ) ( Ⅳ) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 1999, 59- 3968-3671.
  • 6Godthelp BC, Artwert F, Joenje H, et al. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene, 2002,21 : 5002-5005.

共引文献1

同被引文献41

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部